Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules

Publisher： Karger

E-ISSN： 1423-0232|84|2|92-99

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.2, 2012-11, pp. : 92-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiandrogen Monotherapy: Recommendations for the Treatment of Prostate Cancer

By  

Urologia Internationalis, Vol. 72, Iss. 2, 2004-02 ,pp. : 91-98

Karger

Access to resources Recommend Favorite

Changes in Diffusion-Weighted Images for Visualizing Prostate Cancer during Antiandrogen Therapy: Preliminary Results

By  

Urologia Internationalis, Vol. 85, Iss. 4, 2010-11 ,pp. : 421-426

Karger

Access to resources Recommend Favorite

The Effect of Bisphosphonates on Bone Mineral Density in Metastatic Prostate Cancer Patients Who Are Treated with Anti-Androgen Drugs and Radiotherapy

By  

Current Urology, Vol. 7, Iss. 4, 2014-08 ,pp. : 181-184

Karger

Access to resources Recommend Favorite

Antagonist/Agonist Balance of the Nonsteroidal Antiandrogen Bicalutamide (Casodex) in a New Prostate Cancer Model

By  

Urologia Internationalis, Vol. 65, Iss. 2, 2000-10 ,pp. : 73-79

Karger

Access to resources Recommend Favorite

Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-06 ,pp. : 325-330

Karger

Access to resources Recommend Favorite